Astegolimab Completed Phase 2 Trials for Asthma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02918019A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma